Telomere dysfunction provokes regional amplification and deletion in cancer genomes

Cancer Cell

Volumn 2, Issue 2, 2002, Pages 149-155

  O'Hagan, Rónán C ^a,b,e   Chang, Sandy ^a,b,c   Maser, Richard S ^a,b   Mohan, Ramya ^a,b   Artandi, Steven E ^d   Chin, Lynda ^a,b   DePinho, Ronald A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d STANFORD UNIVERSITY   (United States)

^e AVEO ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE LOCUS; GENE TRANSLOCATION; GENOME; GENOMIC INSTABILITY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE; ANIMAL; CHROMOSOME; CHROMOSOME ABERRATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; SYNTENY; TUMOR SUPPRESSOR GENE;

DNA; RNA; TELOMERASE; TELOMERASE RNA;

ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOMES, MAMMALIAN; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DELETION; GENES, P53; GENOME; HUMANS; MICE; NEOPLASMS; RNA; SYNTENY; TELOMERASE; TELOMERE;

EID: 0000839280     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00094-6     Document Type: Article

References (53)

1. Aman, P., Pejovic, T., Wennborg, A., Heim, S., and Mitelman, F. (1993). Mapping of the 19p13 breakpoint in an ovarian carcinoma between the INSR and TCF3 loci. Genes Chromosomes Cancer 8, 134-136.
2. Armitage, P., and Doll, R. (1954). The age distribution of cancer and a multi-stage theory of carcinogensis. Br. J. Cancer 8, 1-12.
3. Artandi, S.E., Chang, S., Lee, S.L., Alson, S., Gottlieb, G.J., Chin, L., and DePinho, R.A. (2000). Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645.
4. Atkin, N.B., and Fox, M.F. (1992). Possibly identical marker chromosome der(16)t(?13;16)(?q13or14;q22) in a squamous cell carcinoma of the skin and larynx. Cancer Genet. Cytogenet. 58, 198-200.
5. Bohr, V.A., and Dianov, G.L. (1999). Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 81, 155-160.
6. Bohr, V., Anson, P.M., Mazur, S., and Dianov, G. (1998). Oxidative DNA damage processing and changes with aging. Toxicol. Lett. 102-103, 47-52.
7. Broccoli, D., Godley, L.A., Donehower, L.A., Varmus, H.E., and de Lange, T. (1996). Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765-3772.
8. Castro, P.D., Fairman, J., and Nagarajan, L. (1998). The unexplored 5q13 locus: a role in hematopoietic malignancies. Leuk. Lymphoma 30, 443-448.
9. Castro, P.D., Liang, J.C., and Nagarajan, L. (2000). Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms. Blood 95, 2138-2143.
10. Chadeneau, C., Hay, K., Hirte, H.W., Gallinger, S., and Bacchetti, S. (1995). Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55, 2533-2536.
11. Chen, X., Johns, D.C., Geiman, D.E., Marban, E., Dang, D.T., Hamlin, G., Sun, R., and Yang, V.W. (2001). Kruppel-like factor 4 (gut-enriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem. 276, 30423-30428.
12. Chin, L., Artandi, S.E., Shen, Q., Tam, A., Lee, S.L., Gottlieb, G.J., Greider, C.W., and DePinho, R.A. (1999). p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527-538.
13. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. (1992). Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929.
14. Dang, D.T., Mahatan, C.S., Dang, L.H., Agboola, I.A., and Yang, V.W. (2001). Expression of the gut-enriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 20, 4884-4890.
15. DePinho, R.A. (2000). The age of cancer. Nature 408, 248-254.
16. Elledge, S.J. (1996). Cell cycle checkpoints: preventing an identity crisis. Science 274, 1664-1672.
17. Fairman, J., Wang, R.Y., Liang, H., Zhao, L., Saltman, D., Liang, J.C., and Nagarajan, L. (1996). Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood 88, 2259-2266.
18. Gagos, S., Hopwood, V.L., Iliopoulos, D., Kostakis, A., Karayannakos, P., Yatzides, H., Skalkeas, G.D., and Pathak, S. (1995). Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient. Anticancer Res. 15, 369-378.
19. Gleason, J.E., Korswagen, H.C., and Eisenmann, D.M. (2002). Activation of Wnt signaling bypasses the requirement for RTK/Ras signaling during the C. elegans vulval induction. Genes Dev. 16, 1281-1290.
20. Gogineni, S.K., da Costa, M., and Verma, R.S. (1996). A new translocation, t(5;21)(q13;q22) in acute myelogenous leukemia. Cancer Genet. Cytogenet. 88, 167-169.
21. Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green, D.K., and Allshire, R.C. (1990). Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868.
22. Hodgson, G., Hager, J.H., Volik, S., Hariono, S., Wernick, M., Moore, D., Nowak, N., Albertson, D.G., Pinkel, D., Collins, C., et al. (2001). Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29, 459-464.
23. Jang, K.T., Chae, S.W., Sohn, J.H., Park, H.R., and Shin, H.S. (2002). Coexpression of MUC1 with p53 or MUC2 correlates with Lymph Node Metastasis in Colorectal Carcinomas. J. Korean Med. Sci. 17, 29-33.
24. Jenkins, R.B., Bartelt, D., Jr., Stalboerger, P., Persons, D., Dahl, R.J., Podratz, K., Keeney, G., and Hartmann, L. (1993). Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet. Cytogenet. 71, 76-86.
25. Karanjawala, Z.E., Grawunder, U., Hsieh, C.L., and Lieber, M.R. (1999). The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 9, 1501-1504.
26. Karanjawala, Z.E., Murphy, N., Hinton, D.R., Hsieh, C.L., and Lieber, M.R. (2002). Oxygen metabolism causes chromosome breaks and is associated with the neuronal apoptosis observed in DNA double-strand break repair mutants. Curr. Biol. 12, 397-402.
27. Kiechle-Schwarz, M., Bauknecht, T., Schmidt, J., Walz, L., and Pfleiderer, A. (1995). Recurrent cytogenetic aberrations in human ovarian carcinomas. Cancer Detect. Prev. 19, 234-243.
28. Kimmel, M., Axelrod, D.E., and Wahl, G.M. (1992). A branching process model of gene amplification following chromosome breakage. Mutat. Res. 276, 225-239.
29. Kipling, D., and Cooke, H.J. (1990). Hypervariable ultra-long telomeres in mice. Nature 347, 400-402.
30. Larramendy, M.L., Lushnikova, T., Björkqvist, A.M., Wistuba, I.I., Virmani, A.K., Shivapurkar, N., Gazdar, A.F., and Knuutila, S. (2000). Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet. Cytogenet. 119, 132-138.
31. Lengauer, C. (2001). How do tumors make ends meet? Proc. Natl. Acad. Sci. USA 98, 12331-12333.
32. Lo, A.W.I., Sprung, C.N., Fouladi, B., Pedram, M., Sabatier, L., Ricoul, M., Reynolds, G.E., and Murnane, J.P. (2002). Chromosome instability as a result of double-strand breaks near telomeres in mouse embryonic stem cells. Mol. Cell. Biol. 22, 4836-4850.
33. Loveday, R.L., Greenman, J., Drew, P.J., Monson, J.R., and Kerin, M.J. (1999). Genetic changes associated with telomerase activity in breast cancer. Int. J. Cancer 84, 516-520.
34. Lu, X., Magrane, G., Yin, C., Louis, D.N., Gray, J., and Van Dyke, T. (2001). Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability. Mol. Cell. Biol. 21, 6017-6030.
35. Narla, G., Heath, K.E., Reeves, H.L., Li, D., Giono, L.E., Kimmelman, A.C., Glucksman, M.J., Narla, J., Eng, F.J., Chan, A.M., et al. (2001). KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294, 2563-2566.
36. Nojima, H. (1997). Cell cycle checkpoints, chromosome stability and the progression of cancer. Hum. Cell 10, 221-230.
37. O'Driscoll, M., Cerosaletti, K.M., Girard, P.M., Dai, Y., Stumm, M., Kysela, B., Hirsch, B., Gennery, A., Palmer, S.E., Seidel, J., et al. (2001). DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8, 1175-1185.
38. Olinski, R., Jaruga, P., and Zastawny, T.H. (1998). Oxidative DNA base modifications as factors in carcinogenesis. Acta Biochim. Pol. 45, 561-572.
39. Orsetti, B., Courjal, F., Cuny, M., Rodriguez, C., and Theillet, C. (1999). 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification. Oncogene 18, 6262-6270.
40. Pipiras, E., Coquelle, A., Bieth, A., and Debatisse, M. (1998). Interstitial deleteions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. EMBO J. 17, 325-333.
41. Prowse, K.R., and Greider, C.W. (1995). Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818-4822.
42. Richard, F., Pacyna-Gengelbach, M., Schlüns, K., Fleige, B., Winzer, K.J., Szymas, J., Dietel, M., Petersen, I., and Schwendel, A. (2000). Patterns of chromosomal imbalances in invasive breast cancer. Int. J. Cancer 89, 305-310.
43. Rudolph, K.L., Millard, M., Bosenberg, M.W., and DePinho, R.A. (2001). Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155-159.
44. Scherl-Mostageer, M., Sommergruber, W., Abseher, R., Hauptmann, R., Ambros, P., and Schweifer, N. (2001). Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene 20, 4402-4408.
45. Shabtai, F., Sternberg, A., Klar, D., Halbrecht, I., and Reiss, R. (1988). Familial fragile 8q22 involved as a cancer breakpoint in cells of a large bowel tumor. Cancer Genet. Cytogenet. 31, 113-118.
46. Sharpless, N.E., Ferguson, D.O., O'Hagan, R.C., Castrillon, D.H., Lee, C., Farazi, P.A., Alson, S., Fleming, J., Morton, C.C., Frank, K., et al. (2001). Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol. Cell 8, 1187-1196.
47. Shen, C.Y., Yu, J.C., Lo, Y.L., Kuo, C.H., Yue, C.T., Jou, Y.S., Huang, C.S., Lung, J.C., and Wu, C.W. (2000). Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 60, 3884-3892.
48. Shie, J.L., Chen, Z.Y., Fu, M., Pestell, R.G., and Tseng, C.C. (2000). Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res. 28, 2969-2976.
49. Wang, V.W., Bell, D.A., Berkowitz, R.S., and Mok, S.C. (2001). Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res. 61, 4169-4174.
50. Wassmann, K., and Benezra, R. (2001). Mitotic checkpoints: from yeast to cancer. Curr. Opin. Genet. Dev. 11, 83-90.
51. Windle, B., Draper, B.W., Yin, Y.X., O'Gorman, S., and Wahl, G.M. (1991). A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev. 5, 160-174.
52. Worsham, M.J., Carey, T.E., Benninger, M.S., Gasser, K.M., Kelker, W., Zarbo, R.J., and Van Dyke, D.L. (1993). Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes Chromosomes Cancer 7, 158-164.
53. Zuber, J., Tchernitsa, O.I., Hinzmann, B., Schmitz, A.C., Grips, M., Hellriegel, M., Sers, C., Rosenthal, A., and Schafer, R. (2000). A genome-wide survey of RAS transformation targets. Nat. Genet. 24, 144-152.